Skip to main content

Animations

MJFF Publications

1371 - 1380 of 6456 Results
Title
Year
  • Year
  • 2019
  • 2020
  • 2020
  • 2022
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • Summary Details
    OPEN
    Title: Multimodal Balance Training Supported by Rhythmical Auditory Stimuli in Parkinson’s Disease: A Randomized Clinical Trial
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.3233/jpd-191752
    Citation Count: 41
  • Summary Details
    OPEN
    Title: Microgravity: A Tool for Protein Drug Development
    Journal Name: International Journal of Pharmaceutical Sciences Review and Research
    Publisher: Global Research Online
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.47583/ijpsrr.2020.v64i02.014
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Parkinson disease with mild cognitive impairment: Domain‐specific cognitive complaints predict dementia
    Journal Name: Acta Neurologica Scandinavica
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/ane.13326
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Longitudinal Clinical and Biological Characteristics in Juvenile‐Onset Huntington's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.29251
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Erythroid Differentiation Dependent Interaction of VPS13A with XK at the Plasma Membrane of K562 Cells
    Journal Name: Contact
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1177/25152564231215133
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Anionic nanoplastic contaminants promote Parkinson’s disease–associated α-synuclein aggregation
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1126/sciadv.adi8716
    Citation Count: 210
  • Summary Details
    OPEN
    Title: Inhibition of Parkinson’s disease–related LRRK2 by type I and type II kinase inhibitors: Activity and structures
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1126/sciadv.adk6191
    Citation Count: 44
  • Summary Details
    OPEN
    Title: Predicting cognitive decline in a low‐dimensional representation of brain morphology
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/alz.081611
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Fas gene dosage tunes the extent of lymphoproliferation and T cell differentiation in lupus
    Journal Name: Clinical Immunology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.clim.2023.109874
    Citation Count: 0
  • Summary Details
    OPEN
    Title: LINE-1 retrotransposons drive human neuronal transcriptome complexity and functional diversification
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1126/sciadv.adh9543
    Citation Count: 66
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.